Consistent beneficial effect with GLP-1RA across broad range of kidney function and kidney damage
This video was recorded during the EASD annual meeting 2022 in Stockholm, Sweden.
Prof. Peter Rossing is head of research and chief physician at the Steno Diabetes Center in Copenhagen, Denmark.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: